B+
Bull case
25%
Probability
Target price
$37.69
Analysis reference price unavailable
Analysis 2026-08-05 · RankAlpha Sentiment Codex
GMAB
Genmab A/SCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
DARZALEX worldwide net sales reached $4.207 billion in Q2 2026, supporting Genmab’s royalty engine, while the European TEPKINLY approval and positive DLBCL-4 PFS result broaden epcoritamab’s opportunity set. [#PR-EARNINGS-2026-07-15] [#IR-GMAB-TEPKINLY-2026-07-06]
Posture
Mixed
Lead driver
Sentiment
What changed
3 setup hits (3d) with net bullish as of 2026-09-13.
What can break
Analyst revisions, consensus surprise data, short interest, options data, and post-event price attribution are unavailable in the packet.
Momentum
73
Value
64
Sentiment
55
Setup hits (3d)
3 · Net Bullish
AI TargetsBase $29.02 · Bull $37.69 · Bear $24.67Analysis 2026-08-05; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-11 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-05 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-11
Investment thesis
As of 2026-09-11
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-11. Definitions
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Bullish
Target $39.07
Why
Momentum73 · Δ7d +0.2
Value64 · Δ7d -0.0
Sentiment55 · Δ7d +2.3
So what
Balanced signals (Net Bullish). Wait for confirmation before sizing up.
Confirming evidence
- • 3 setup hits (3d) with net bullish as of 2026-09-13.
- • Sentiment remains the lead driver in the composite, 7D delta +2.3.
Contradictions & invalidation
- • Analyst revisions, consensus surprise data, short interest, options data, and post-event price attribution are unavailable in the packet.
- • EPCORE DLBCL-1 did not meet its U.S. overall-survival primary endpoint. [#IR-GMAB-DLBCL1-2026-07-23]
- • The DLBCL-1 U.S.
Catalyst clock
2026-06-29
DLBCL-4 regulatory and commercial follow-through
Lead driver: Sentiment · See AI snapshot
Momentum
73
9% active weight
Current posture
7d trendImproving
Δ7d
+0.2
Δ21d
+4.6
Value
64
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
55
62% active weight
Current posture
7d trendImproving
Δ7d
+2.3
Δ21d
+4.3
Why this grade
Composite grade C. Momentum 73.4 / Value 64.3 / Sentiment 54.6
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-05. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$29.02
Analysis reference price unavailable
Analysis 2026-08-05 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$24.67
Analysis reference price unavailable
Analysis 2026-08-05 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$19.46B
Beta
0.76
Shares Out
597.02M
P/E (TTM)
13.4
P/S (TTM)
5.65
P/FCF (TTM)
16.83
Rev YoY
+23.0%
EPS YoY
-10.9%
Gross Margin
+93.0%
Op Margin
+32.3%
Net Debt
$3.71B
Current Ratio
2.46
As of 2026-09-11 • Updated nightlySource: Internal modelMethods & Data